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BACKGROUND: Rising colorectal cancer (CRC) screen-
ing rates in the last decade are attributable almost
entirely to increased colonoscopy use. Little is known
about factors driving the increase, but primary care
physicians (PCPs) play a central role in CRC screening
delivery.
OBJECTIVE: Explore PCP attitudes toward screening
colonoscopy and their associations with CRC screening
practice patterns.
DESIGN: Cross-sectional analysis of data from a na-
tionally representative survey conducted in 2006–2007.
PARTICIPANTS: 1,266 family physicians, general practi-
tioners, general internists, and obstetrician-gynecologists.
MAIN MEASURES: Physician-reported changes in the
volume of screening tests ordered, performed or super-
vised in the past 3 years, attitudes toward colonoscopy,
the influence of evidence and perceived norms on their
recommendations, challenges to screening, and prac-
tice characteristics.
RESULTS: The cooperation rate (excludes physicians
without valid contact information) was 75%; 28%
reported their volume of FOBT ordering had increased
substantially or somewhat, and the majority (53%)
reported their sigmoidoscopy volume decreased either
substantially or somewhat. A majority (73%) reported
that colonoscopy volume increased somewhat or
substantially. The majority (86%) strongly agreed that
colonoscopy was the best of the available CRC
screening tests; 69% thought it was readily available
for their patients; 59% strongly or somewhat agreed
that they might be sued if they did not offer colono-
scopy to their patients. All three attitudes were
significantly related to substantial increases in colo-
noscopy ordering.
CONCLUSIONS: PCPs report greatly increased colo-
noscopy recommendation relative to other screening
tests, and highly favorable attitudes about colono-
scopy. Greater emphasis is needed on informed deci-
sion-making with patients about preferences for test
options.
KEY WORDS: colorectal cancer screening; primary care physicians;
colonoscopy screening practices.
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INTRODUCTION AND BACKGROUND
Over the past decade, the US Preventive Services Task Force,
American Cancer Society, American College of Gastroenter-
ology, and other organizations have published guidelines
recommending a number of testing options for colorectal
cancer (CRC) screening.1,2 CRC screening rates continue to be
suboptimal,3,4 and guidelines continue to encourage screening
by one of several effective tests. The prevalence of screening
by colonoscopy specifically, however, has greatly increased
compared with other testing options.5–7 National trend data
show a rise in CRC screening rates since 2000 that is
attributable almost entirely to increased use of colonoscopy.
Even though the increase in colonoscopy use has
been dramatic, little is known about what factors influ-
enced this increase. Numerous studies have illustrated that
patient, provider, practice, and health system factors affect
primary care physician (PCP) behavior related to cancer
screening, 8–10 and the pivotal role of PCPs in recom-
mending and increasing CRC screening is well estab-
lished.11 However, PCPs’ opinions about colonoscopy
have not previously been assessed.
In this study, using data from a nationally representative
survey of practicing PCPs, we (1) investigate physicians’
reports of changes in the past 3 years in the volume of CRC
screening tests that they order, perform or supervise, with a
particular focus on colonoscopy; (2) explore physicians’
attitudes related to colonoscopy and potential associations
of their attitudes with screening colonoscopy practice
patterns; and (3) investigate the relationships of selected
known or postulated factors with the reported changes in
volume of colonoscopy ordering. These data may be helpful
for understanding practice variation and to guide thinking
about future research priorities and potential interventions.
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METHODS
A nationally representative sample of PCPs participated in a
survey between September 2006 and May 2007, sponsored
by the National Cancer Institute (NCI) in collaboration with
the Agency for Healthcare Research and Quality (AHRQ)
and the Centers for Disease Control and Prevention (CDC).
Eligible physicians included office-based family physicians,
general internists, general practitioners, and obstetrician/
gynecologists (OB/GYNs) aged 75 or younger. A sample
of PCPs was selected from the American Medical Associa-
tion’s Physician Masterfile using the four specialties as
sampling strata. Prior to selection, the sampling frame
database was sorted by age, gender, US Census region, and
urban-rural practice location within each stratum. Detailed
survey content and sampling strategy are reported else-
where.12,13 The study was reviewed by the institutional review
boards of the NCI and CDC and determined to be exempt.
In September 2006, 1,975 PCPs were sent a questionnaire
on colorectal and lung cancer screening via express mail, and
several methods were used to encourage participation.14
These methods included letters of endorsement from national
physician organizations, postage-paid return envelopes, a $50
honorarium, two additional mailings, up to three follow-up
telephone reminders to non-respondents, and the option to
complete the survey by telephone. Additional details have
been published elsewhere.12
The dependent measure of interest was physicians’
reports of changes in the volume of screening tests they
ordered, performed, or supervised in the past 3 years for
FOBT, sigmoidoscopy, and colonoscopy. Response catego-
ries were on a 5-point scale (increased substantially,
increased somewhat, stayed the same, decreased somewhat,
or decreased substantially).
Guided by the social ecological perspective—which recog-
nizes the influence of multi-level factors on behavior—and
the Theory of Planned Behavior,15,16 we assessed the
relationship of selected factors with test ordering reports.
The Theory of Planned Behavior highlights the potential
influence on behavior of a physician’s attitudes, perceived
norms, and perceived challenges.
Physicians’ attitudes toward colonoscopy screening
included agreement with three statements: “it is the best of
the available CRC screening tests,” “it is readily available
for my patients,” and “I worry that I might be sued if I do
not offer screening colonoscopy to my patients.” Responses
to these statements were measured on a 4-point scale, from
“strongly agree” to” strongly disagree.” Additionally, we
created a summary measure of the strength of agreement
across the three items: strongly agree with none of the three
items, strongly agree with one of the three items, strongly
agree with two, or strongly agree with all three items.
Three items related to reported influence of perceived
norms. Respondents rated local collegial norms, patient
preferences, and national recommendations (USPSTF, ACS,
and published clinical evidence) on a scale of “very
influential,” “somewhat influential,” and “not influential”
to their practice of CRC screening. Respondents were also
given a “not applicable/not familiar” choice.
With respect to perceived challenges, they were asked how
influential two items were in their recommendations for CRC
screening: the cost of screening tests for patients with no
third party coverage and availability of reimbursement by
third party payers, including Medicare and Medicaid.
Additional measures included individual physician charac-
teristics, that is specialty, age, sex, race, and medical school
affiliation. Practice context measures included size (number of
physicians), geographic location (urban, large rural city/town,
small/isolated rural town), and the practice’s panel of patients,
including percent of uninsured patients. Practice systems
support measures included whether CRC screening guidelines
had been implemented, whether CRC screening reminders
were provided to the physician and/or patients, and type of
medical records system used (paper, in transition, or electronic).
We used descriptive statistics to examine reported changes
in ordering by test type, reports of agreement with attitudes
concerning colonoscopy, and the distribution of factors
potentially associated with physicians’ colonoscopy test
ordering. Further, we used chi-square statistics to assess the
bivariate associations of these measures with the reported
change in colonoscopy ordering. Variables with an associa-
tion at p<0.10 were retained for multivariate models.
Polytomous logistic regression models assessed factors
associated with changes in colonoscopy ordering. We
estimated two models: one with the three attitude items
included separately as covariates and one with a summary
attitude measure as a single covariate. We used the statistical
program SUDAAN version 9.1 to account for the complex
survey design and to incorporate survey weights to obtain
national estimates. Analyses were conducted in 2010–2011.
RESULTS
Description of Respondents
As previously reported, 1,266 PCPs responded to the survey
on colorectal and lung cancer screening.12 The survey’s
absolute response rate was 69.3% and cooperation rate
(excludes physicians lacking valid contact information) was
75.0%. Physicians’ personal and practice characteristics are
reported in Table 1. These characteristics produced by the
weighted analyses are nationally representative of practicing
PCPs in the US. The majority of respondents were male,
non-Hispanic white, not affiliated with a medical school, in
solo or small group practices, and in urban environments. The
majority reported that a low proportion of their patients were
uninsured, CRC screening guidelines were implemented in
the practice, and they used paper rather than electronic
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medical records. A minority reported systems in place for
CRC screening reminders for the physician or the patient.
Changes in Test Ordering In Past 3 Years
As reported in Figure 1, 28% of respondents reported
their volume of FOBT ordering had increased substan-
tially or somewhat. In contrast, the majority (53%)
reported their sigmoidoscopy volume had decreased
either substantially or somewhat. The vast majority




Figure 2 and Table 2 (see “total” column) show PCPs’
attitudes about colonoscopy. The majority (86%) strongly
agreed that colonoscopy was the best of the available CRC
screening tests. A smaller proportion (69%) thought it was
readily available for their patients. Asked whether they
might be sued if they did not offer colonoscopy to their
patients, 59% either strongly or somewhat agreed and 42%
somewhat or strongly disagreed. The majority of respond-
ents (53%) strongly agreed with two of the three items, and
14% agreed with all three items.
As shown in Table 2, 56% of PCPs indicated that local
collegial norms were very or somewhat influential in their
screening practices and 80% that patient preferences were
very or somewhat influential. A majority reported ACS
(69%) and USPSTF guidelines (68%) and published clinical
evidence (72%) as very influential. In response to two
measures related to financial issues, 81% reported that the
cost of CRC screening tests for patients with no third party
coverage was very or somewhat influential, while 65%
reported that reimbursement availability by third party
payers was very or somewhat influential.
Factors Associated with Reported Change
in Colonoscopy Ordering
Table 2 also shows the bivariate relationships of attitudes,
perceived norms, and challenges with reported changes in
colonoscopy ordering. The three individual colonoscopy
attitude measures were each significantly related to report-
ing substantial increases in colonoscopy ordering as was the
summary measure (Fig. 3). Table 3 shows the findings of
the regression analyses. Agreement with the three individ-
ual attitude measures was significantly related to reporting
substantial increases in colonoscopy ordering compared to
other reports. Those who opined it was the best available
test, strongly or somewhat agreed it was readily available,
or strongly or somewhat agreed or somewhat disagreed they
worried they might be sued were more likely to report a
substantial increase in colonoscopy ordering.
With respect to other physician perception measures
(influence of norms and patient preference and challenges),
only one was independently related to increased colono-
scopy ordering. PCPs who indicated that availability of
third party reimbursement for CRC screening tests was very
influential in their recommendations were significantly
more likely to report substantially increased colonoscopy
ordering than were PCPs who said that third party
reimbursement was somewhat or not influential.
Several individual-level demographic measures were
independently associated, notably specialty and age. Two
practice-level measures, having CRC screening guidelines
Table 1. Physician and Practice Characteristics (n=1,266)
Unweighted n Weighted %
Specialty
Family, general practice 547 45.2










Non-Hispanic White 925 72.1










Large rural city/town‡ 133 10.2











Don’t know/missing 59 4.5






Type of medical record‖
Paper 709 56.4
Partial/in transition to electronic 329 26.1
Full electronic 218 17.3
*Includes American Indian/Alaska Native, Native Hawaiian/Other
Pacific Islander, Multiple races, Other race, and Unknown
†Rural Urban Commuting Area (RUCA) 2 codes 1.0, 1.1, 2.0, 2.1, 3.0,
4.1, 7.1
‡RUCA2 codes 4.0, 4.2, 5.0, 5.2, 6.0
§RUCA2 codes 7.0, 7.2, 7.3, 7.4, 8.0, 8.2, 8.3, 9.0, 9.1, 10.0, 10.2,
10.4, 10.5, 10.6
‖In main practice location
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implemented in the practice and having EMR partially or
fully in place, were related to reporting a substantial
increase in colonoscopy ordering.
Table 4 shows the findings of the polytomous logistic
regression model that included the attitude summary
measure (other item findings not reported in table). Those
who strongly agreed with one or more of the three
colonoscopy attitude items were significantly more likely
to have substantially or somewhat increased their ordering
of colonoscopy. The magnitude of the odds ratios increased
Figure 1. Reported change over the past 3 years in volume of CRC screening procedures that PCPs order, perform, or supervise.
Figure 2. PCPs’ attitudes about screening colonoscopy.
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incrementally with the number of items with which the
physician agreed. Other significant items in this model
remained essentially the same as the first model.
DISCUSSION
This national survey confirms other studies documenting
greatly increased recommendation and use of colonoscopy
for CRC screening.5–7,17 Only a decade ago, a national
survey conducted by NCI showed that very small propor-
tions of PCPs endorsed colonoscopy as the CRC screening
test they most often recommended to their patients.18
Following that survey, in 2001, the Centers for Medicare
and Medicaid Services added coverage of screening
colonoscopy for average-risk Medicare beneficiaries.19 In
2002, the US Preventive Services Task Force (USPSTF)
added colonoscopy to the menu of recommended options
for CRC screening,20 but did not single out one test as more
effective than other recommended options, which included
FOBT and sigmoidoscopy. Thus, when our data were
collected, all major organizations were unanimous in saying
that any of several CRC screening strategies were appro-
priate. Colonoscopy also was not considered the best test in
quantitative analyses performed by the USPSTF and the
Institute of Medicine.21 Further, guidelines explicitly rec-
ommended that physicians discuss available test options
with their patients and that choices among options be made
based on cost, availability, convenience, and personal
preference. However, as we and others have documented,
discussing these options with patients does not appear to be
routine practice for most PCPs,22 and PCPs’ discussions with
patients about CRC screening are cursory and omit explana-













It is the best of the available tests
Strongly agree 90.3 87 79.3 86.3
Somewhat agree 8.6 11.3 16.1 11.4
Somewhat disagree/strongly disagree 1.1 1.7 4.7 2.2 0.004
It is readily available for my patients
Strongly agree 78 64.3 60.9 69.1
Somewhat agree 18.7 27.4 26.3 23.5
Somewhat disagree/strongly disagree 3.3 8.2 12.8 7.4 <0.001
I worry I might be sued if I do not offer this test
Strongly agree 23.2 17.6 17.3 19.9
Somewhat agree 43 38.1 32 38.6
Somewhat disagree 21.9 25.4 26.5 24.2
Strongly disagree 11.8 18.9 24.2 17.3 0.0016
Summary measure of 3 colonoscopy attitudes
Strongly agree with none 3.9 5.8 13.8 7.1
Strongly agree with one 19.9 31.3 28.1 25.7
Strongly agree with two 57.9 52.2 47.0 53.2
Strongly agree with three 18.2 10.7 11.1 13.9 <0.001
Local collegial norms
Very influential 18.6 14.2 12.9 15.7
Somewhat influential 37.5 41.4 42.9 40.1
Not Influential 43.9 44.4 44.2 44.1 0.1988
Patient norms (perceptions of Patient preferences)
Very influential 26.5 25.8 26.9 26.4
Somewhat influential 52.9 55 52.2 53.4
Not influential 20.5 19.2 20.9 20.2 0.9575
USPSTF
Very influential 72 66.7 62.9 68
Somewhat influential 26.8 31.1 34.7 30.2
Not influential 1.2 2.2 2.3 1.8 0.1178
ACS
Very influential 70.7 68.8 66.7 69.1
Somewhat influential 28.1 30.6 30.1 29.4
Not influential 1.2 0.6 3.1 1.5 0.3172
Clinical published evidence
Very influential 78.3 66.4 66.9 71.5
Somewhat influential 20.5 32.7 32.5 27.6
Not influential 1.2 0.9 0.6 0.9 0.0002
Cost for patients who lack 3rd party insurance coverage
Very influential 32.3 32.5 27.2 31
Somewhat influential 51.1 48.7 51.2 50.4
Not influential 16.6 18.8 21.6 18.6 0.2675
Reimbursement available by 3rd party payers
Very influential 30.2 26.7 20.4 26.5
Somewhat influential 36.6 40.8 37.3 38.1
Not influential 33.1 32.5 42.3 35.3 0.0015
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tion of procedure risks.23,24 Instead, colonoscopy—the most
expensive option that also carries significant risk 25—has
become the screening test choice in the US.
Why has colonoscopy recommendation and ordering
overwhelmed other colorectal cancer screening tests? Our
data provide insights into influences that may be driving this
change. A large proportion of PCPs (70%) viewed colono-
scopy as the best of the available colorectal cancer screening
tests. The majority (64%) strongly agreed that colonoscopy
testing was readily available for their patients. More than
half (58%) strongly or somewhat agreed that they worried
they might be sued if they did not offer screening colono-
scopy to their patients. Strong agreement with each of these
three attitude items was independently and significantly
related to PCPs’ reports of substantially increased colono-
scopy ordering. To our knowledge, these attitude questions
about being the best available test and fear of lawsuits have
not been asked before in a national survey. They provide a
credible explanation for increased referral to colonoscopy but
do not elucidate how these opinions were shaped.
The proportion of PCPs feeling strongly about being sued
is curious.26 Interestingly, gastroenterologists may fear
being sued because of injury during colonoscopy, but PCPs
may be concerned about not recommending the perceived
“gold standard.”27 Gastroenterologists who perform the
procedure may be particularly important in influencing its
use.28 For example, one newspaper advertisement was
titled: "Your golden years deserve the gold standard of
colon cancer screening."29 The number of websites and
blogs advocating colonoscopy30 as the gold standard may
reflect marketing to PCPs as well as to the public who
increasingly use the web for health information.31
From the community perspective, it is important to note that
31% of respondents reported that colonoscopy was not
readily available for their patients. If accurate, this perception
may reflect lower specialist capacity in certain geographical
areas or regional variation in practice patterns.32 Medicare
coverage of screening colonoscopy may have lessened the
concern about patients not having insurance and increased
the ordering of colonoscopy.33 These effects may increase
following implementation of the Affordable Health Care Act,
which provides coverage without co-payments.34
However, access to CRC screening remains an issue
given persistent evidence of disparities for certain racial/
ethnic groups, individuals with low socioeconomic status,
and the uninsured.17 Subramanian and colleagues35 argue
that, at the population level and in an era of tight budgets,
screening patients with FOBT as opposed to colonoscopy
would result in more people being screened and a greater
gain in life-years. As discussed in the 2010 NIH State of the
Science Conference on Enhancing Use and Quality of
Colorectal Cancer Screening, continued heavy reliance on
screening colonoscopy is unlikely to facilitate attainment of
high rates of CRC screening because current capacity to
provide this procedure to the millions of adults aged 50–75
who have not been screened may be insufficient.4
Practice level measures were also significantly related to
reports of increased colonoscopy ordering. Numerous
studies have highlighted the major role of reminder systems
in increasing screening prevalence.9 In our analyses, while
reminders were not independently related to reports of
increased colonoscopy recommendation, physicians in
practices with partial or full electronic medical record
systems were more likely to report substantial increases in
Figure 3. Reported change over past 3 years in volume of colonoscopy ordering by strong agreement with three attitude items.
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colonoscopy ordering. Perhaps EMRs cue more efficiently
and therefore result in more ordering.36,37
We found that OB/GYNs were less likely than other
PCPs to report substantial increases in colonoscopy order-
ing. This difference may be a reflection of the younger
patient population that is typically seen by OB/GYNs. It
also could be related to their propensity to use in-office
FOBT.38 Another differentiating physician characteristic
was age. Older PCPs were more likely to report substan-
tially increased use of screening colonoscopy. The expla-
nation for this is speculative, but perhaps younger
physicians have been ordering more colonoscopy right
along while older physicians report an increase given
changes in coverage over the years.
We acknowledge several limitations of this study. While
we investigated three potential attitudes’ relationship to
increases in screening colonoscopy, there may indeed be
other factors worthy of investigation. Additionally, our
study does not include the patient perspective. It is based on
a physician survey, and direct patient reports therefore were
beyond its scope. We attempted to assess the extent to which
physicians were influenced by patients’ preferences, but our
measure may have been too indirect and subject to socially
desirable responses. A more direct assessment, such as “How
often do your patients ask specifically for screening colono-
scopy,” could be informative in future research. Our
assessment of what physicians thought was the best test
was also limited, and we did not ask how often PCPs use
personalized discussion to determine the best test for each
patient. This issue should be addressed in future study. For
example, how would recommendations be modified in the
presence or absence of a family history of colorectal
cancer or a family or personal history of adenomatous
polyps?1,21 The survey items were not explicit about the
categorization of FOBT and FIT tests. Finally, we
analyzed physicians’ reports of their practice patterns
without corroborating evidence from chart reviews or
insurance claims. Some studies have reported that physi-
cians overestimate their screening recommendations,39
while a more recent report documented the reliability of
physician self-report of preventive care activities.40 Other
Table 3. Polytomous Logistic Regression Model and Measures













It is the best of the available tests
Strongly agree 5.3(1.6–17.9) 3.0(1.0–9.7)




It is readily available for
my patients
Strongly agree 3.7(1.9–7.2) 1.7(0.9–3.2)




I worry I might be sued
if I do not offer this test
Strongly agree 2.0(1.1–3.6) 1.2(0.7–2.1)
Somewhat agree 2.2(1.3–3.7) 1.6(1.0–2.6)
Somewhat disagree 1.9(1.2–3.0) 1.5(0.9–2.5)
Strongly disagree 1.0(1.0–1.0) 1.0(1.0–1.0)
Clinical published evidence
Very influential 0.6(0.1–4.2) 1.0(0.2–5.4)
Somewhat influential 0.4(0.1–2.6) 1.1(0.2–6.0)
Not influential 1.0(1.0–1.0) 1.0(1.0–1.0)
3rd party reimbursement
Very influential 1.7(1.2–2.5) 1.5(1.0–2.3)
Somewhat influential 1.2(0.8–1.8) 1.3(0.9–1.9)













Non-Hispanic White 1.0(1.0–1.0) 1.0(1.0–1.0)

















MD reminders in place
Yes 1.1(0.8–1.7) 1.2(0.8–1.8)
No 1.0(1.0–1.0) 1.0(1.0–1.0)












Table 4. Polytomous Logistic Regression Model and Summary
Attitude Measure Associated with Changes in Colonoscopy
Ordering (Other Measures Not Reported Here)
Increased substantially
compared with stayed
the same or decreased
Increased somewhat
compared with
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validation studies support use of survey data for profiling
CRC screening trends and patterns.7
SUMMARY
This study strongly confirms the significant increases in
colonoscopy ordering for CRC screening in other national
reports, and the findings provide insight into factors related to
PCPs’ recommendations and ordering practices. It is important
to note, particularly in an era of increasing social media, that
additional normative factors may influence attitudes, as well as
other factors that we were unable to assess in this survey.
Clearly, influences in addition to practice guidelines are
shaping PCPs’ recommendations. Perhaps engaging clini-
cians in discussion about screening test efficacy, availabil-
ity, costs, and harms, as well as the legitimacy of litigation
fears, could promote more acceptance of recommendations
that call for patient-centered decision making. While CRC
screening use has been increasing in the US, a significant
proportion of the adult population remains unscreened,
and encouraging patient and physician discussions about
options for screening may help to increase appropriate use
and address disparities. Interventions might include those
to promote increased CRC screening and shared decision
making since both are consistent with health care reform
and other efforts that emphasize evidence-based practice,
the patient-centered medical home, and enhanced access
and cost-effectiveness.41
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